DR. ROBERT MERRILL HUNTER, MD
Radiology at New Bern Ave, Raleigh, NC
License number
North Carolina 29123
Category
Radiology
Type
Thoracic Surgery (Cardiothoracic Vascular Surgery)
Address
Address
3000 New Bern Ave SUITE 1100, Raleigh, NC 27610
Phone
(919) 231-6333
(919) 231-6334 (Fax)
(919) 231-6334 (Fax)
Personal information
See more information about ROBERT MERRILL HUNTER at radaris.comName
Address
Phone
512 Thornburg Rd, Dallas, NC 28034
5113 Accessto Ln, Hope Mills, NC 28348
5116 Masonboro Loop Rd, Wilmington, NC 28409
50 Rabbit Run, Brevard, NC 28712
441 Forest Heights Dr, Marion, NC 28752
Professional information
See more information about ROBERT MERRILL HUNTER at trustoria.com
Retired Program Manager (Ibm)
Retired Program Manager (Ibm)
Position:
Retired Program Manager at IBM Corp.
Location:
Raleigh-Durham, North Carolina Area
Industry:
Information Technology and Services
Work:
IBM Corp.
-
Retired Program Manager
Oxy
Jan 1972 - Aug 1978
-
Manager, Chemical Quality Control
Education:
Lawrence Technological University 1970 - 1972
B.S., Business
B.S., Business
Skills:
Project Management, Program Management, Business Analysis, Change Management, Project Planning, Team Leadership
Dr. Robert M Hunter, Raleigh NC - MD (Doctor of Medicine)
Dr. Robert M Hunter, Raleigh NC - MD (Doctor of Medicine)
Specialties:
Cardiac Surgery
Address:
Carolina Cardiovascular Sgcl
3000 New Bern Ave SUITE 1100, Raleigh 27610
(919) 231-6333 (Phone)
3000 New Bern Ave SUITE 1100, Raleigh 27610
(919) 231-6333 (Phone)
Procedures:
Coronary Angioplasty, Atherectomy and Stent
Conditions:
Congestive Heart Failure, Heart Attack (Acute Myocardial Infarction)
Certifications:
General Surgery, 1994, Thoracic Cardiovascular Surgery, 1986
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Wake Forest University School Of Medicine, Medical Center Boulevard
Graduated: 1978
Vanderbilt University Hospital
Graduated: 1979
Emory University Hospital
Graduated: 1985
Graduated: 1983
Wake Forest University School Of Medicine, Medical Center Boulevard
Graduated: 1978
Vanderbilt University Hospital
Graduated: 1979
Emory University Hospital
Graduated: 1985
Graduated: 1983
Member Of Technical Staff At Netapp
Member Of Technical Staff At Netapp
Position:
Member of Technical Staff at NetApp
Location:
Raleigh-Durham, North Carolina Area
Industry:
Computer Software
Work:
NetApp
- Raleigh-Durham, North Carolina Area since Apr 2007
-
Member of Technical Staff
Education:
Carnegie Mellon University 2002 - 2006
BS, Computer Science
BS, Computer Science
Languages:
Spanish
Robert Merrill Hunter, Raleigh NC
Robert Merrill Hunter, Raleigh NC
Specialties:
Cardiothoracic Surgeon
Address:
3000 New Bern Ave, Raleigh, NC 27610
Education:
Wake Forest University, School of Medicine - Doctor of Medicine
Board certifications:
American Board of Thoracic Surgery Certification in Thoracic and Cardiac Surgery (Thoracic Surgery)
Robert Merrill Hunter, Raleigh NC
Robert Merrill Hunter, Raleigh NC
Specialties:
Thoracic Surgery, Cardiothoracic Vascular Surgery, Thoracic Surgery, Cardiothoracic Vascular Surgery
Work:
Carolina Cardiovascular Surgic
3000 New Bern Ave, Raleigh, NC 27610 Carolina Cardiovascular Assoc
3000 New Bern Ave, Raleigh, NC 27610
3000 New Bern Ave, Raleigh, NC 27610 Carolina Cardiovascular Assoc
3000 New Bern Ave, Raleigh, NC 27610
Education:
Vanderbilt University Hospital (1983) *, Emory University Hospital (1985) *
Robert Hunter - Raleigh, NC
Robert Hunter - Raleigh, NC
Work:
Medicinal Chemistry, GlaxoSmithKline
Investigator GlaxoWellcome Inc - Durham, NC
Sr. Scientist Burroughs Wellcome Co - Durham, NC
Research Assistant Imperial Chemical Industries - Goldsboro, NC
Co-op Residue Chemistry Technician
Investigator GlaxoWellcome Inc - Durham, NC
Sr. Scientist Burroughs Wellcome Co - Durham, NC
Research Assistant Imperial Chemical Industries - Goldsboro, NC
Co-op Residue Chemistry Technician
Education:
North Carolina State University - Raleigh, NC
BS in Chemistry Wayne Community College - Goldsboro, NC
Associate in Science
BS in Chemistry Wayne Community College - Goldsboro, NC
Associate in Science
Benzylidene-1,3-Dihydro-Indol-2-One Derivatives A Receptor Tyrosine Kinase Inhibitors, Particularly Of Raf Kinases
Benzylidene-1,3-Dihydro-Indol-2-One Derivatives A Receptor Tyrosine Kinase Inhibitors, Particularly Of Raf Kinases
US Patent:
6268391, Jul 31, 2001
Filed:
Apr 7, 2000
Appl. No.:
9/446586
Inventors:
Scott Howard Dickerson - Chapel Hill NC
Philip Anthony Harris - Raleigh NC
Robert Neil Hunter - Raleigh NC
David Kendall Jung - Durham NC
Karen Elizabeth Lackey - Hillsborough NC
Robert Walton McNutt - Durham NC
Michael Robert Peel - Chapel Hill NC
James Marvin Veal - Apex NC
Philip Anthony Harris - Raleigh NC
Robert Neil Hunter - Raleigh NC
David Kendall Jung - Durham NC
Karen Elizabeth Lackey - Hillsborough NC
Robert Walton McNutt - Durham NC
Michael Robert Peel - Chapel Hill NC
James Marvin Veal - Apex NC
Assignee:
Glaxo Wellcome Inc. - Research Triangle Park NC
International Classification:
A61K 31404, C07D20934
US Classification:
514418
Abstract:
Compounds of general formula (I) wherein: R. sup. 1 is H or optionally joined with R. sup. 2 to form a fused ring selected from the group consisting of five to ten membered aryl, heteroaryl or heterocyclyl rings, R. sup. 2 and R. sup. 3 are independently H, HET, aryl, C. sub. 1-12 aliphatic, CN, NO. sub. 2, halogen, R. sup. 10, --OR. sup. 10, --SR. sup. 10, --S(O)R. sup. 10, --SO. sub. 2 R. sup. 10, --NR. sup. 10 R. sup. 11, --NR. sup. 11 R. sup. 12, --NR. sup. 12 COR. sup. 11, --NR. sup. 12 CO. sub. 2 R. sup. 11, --NR. sup. 12 CONR. sup. 11 R. sup. 12, --NO. sup. 12 SO. sub. 2 R. sup. 11, --NR. sup. 12 C(NR. sup. 12)NHR. sup. 11, --COR. sup. 11, --CO. sub. 2 R. sup. 11, --CONR. sup. 12 R. sup. 11, --SO. sub. 2 NR. sup. 12 R. sup. 11, --OCONR. sup. 12 R. sup. 11, C(NR. sup. 12)NR. sup. 12 R. sup. 11, R. sup. 6 and R. sup. 7 are independently halogen, CN, NO. sub. 2, --CONR. sup. 10 R. sup. 11, --SO. sub. 2 NR. sup. 10 R. sup. 11, --NR. sup. 10 R. sup.
Substituted Oxindole Derivatives As Protein Tyrosine Kinase And As Protein Serine/Threonine Kinase Inhibitors
Substituted Oxindole Derivatives As Protein Tyrosine Kinase And As Protein Serine/Threonine Kinase Inhibitors
US Patent:
2003000, Jan 2, 2003
Filed:
Aug 8, 2001
Appl. No.:
09/924431
Inventors:
Stephen Davis - Durham NC, US
Scott Dickerson - Chapel Hill NC, US
Stephen Frye - Durham NC, US
Philip Harris - Raleigh NC, US
Robert Hunter - Raleigh NC, US
Lee Kuyper - Durham NC, US
Karen Lackey - Hillsborough NC, US
Michael Luzzio - Groton CT, US
James Veal - Apex NC, US
Duncan Walker - Summit NJ, US
Scott Dickerson - Chapel Hill NC, US
Stephen Frye - Durham NC, US
Philip Harris - Raleigh NC, US
Robert Hunter - Raleigh NC, US
Lee Kuyper - Durham NC, US
Karen Lackey - Hillsborough NC, US
Michael Luzzio - Groton CT, US
James Veal - Apex NC, US
Duncan Walker - Summit NJ, US
International Classification:
C 07D 4 3/02, C 07D 2 9/56, C07D209/34
US Classification:
546/200000, 548/361100, 548/432000, 548/486000
Abstract:
Compounds of formula (I): wherein X is N, CH, CCF, or C(Caliphatic); Ris sulfonic acid, Caliphatic-sulfonyl, sulfonyl-Caliphatic, Caliphatic-sulfonyl-Caliphatic, Caliphatic-amino, R-sulfonyl, Rsulfonyl-Caliphatic, R-aminosulfonyl, R-aminosulfonyl-Caliphatic, R-sulfonylamino, R-sulfonylamino-Caliphatic, aminosulfonylamino, di-Caliphatic amino, di-Caliphatic aminocarbonyl, di-Claliphatic aminosulfonyl, di-Caliphatic amino, di-Caliphatic aminocarbonyl, di-Caliphatic aminosulfonyl-Caliphatic, (R)-Arylamino, (R)-Arylsulfonyl, (R)-Aryl-aminosulfonyl, (R)-Aryl-sulfonylamino, Het-amino, Het-sulfonyl, Het-aminosulfonyl, aminoiminoamino, or aminoiminoaminosulfonyl, Ris hydmogen; and further wherein Rand Rare optionally joined to form a fused ring, pharmaceutical formulations comprising them and their use in therapy, especially in the treatment of diseases mediated by CDK2 activity, such as alopecia induced by cancer chemotherapy or radiotherapy.
Substituted Oxindole Derivatives As Protein Tyrosine And As Protein Serine/Threonine Kinase Inhibitors And Compositions And Methods Of Treating Chemotherapy And Radiation Therapy Side Effects
Substituted Oxindole Derivatives As Protein Tyrosine And As Protein Serine/Threonine Kinase Inhibitors And Compositions And Methods Of Treating Chemotherapy And Radiation Therapy Side Effects
US Patent:
2003006, Apr 10, 2003
Filed:
Nov 30, 2001
Appl. No.:
09/999331
Inventors:
Stephen Davis - Durham NC, US
Scott Dickerson - Chapel Hill NC, US
Stephen Frye - Durham NC, US
Philip Harris - Raleigh NC, US
Robert Hunter - Raleigh NC, US
Lee Kuyper - Durham NC, US
Karen Lackey - Hillsborough NC, US
Michael Luzzio - Groton CT, US
James Veal - Apex NC, US
Duncan Walker - Summit NJ, US
Scott Dickerson - Chapel Hill NC, US
Stephen Frye - Durham NC, US
Philip Harris - Raleigh NC, US
Robert Hunter - Raleigh NC, US
Lee Kuyper - Durham NC, US
Karen Lackey - Hillsborough NC, US
Michael Luzzio - Groton CT, US
James Veal - Apex NC, US
Duncan Walker - Summit NJ, US
International Classification:
C 07D 4 1/02, C07D209/34
US Classification:
546/277700, 548/486000
Abstract:
Compounds of formula (I): wherein X is N, CH, CCF, or C(Caliphatic); Ris sulfonic acid, Caliphatic-sulfonyl, sulfonyl-Caliphatic, Caliphatic-sulfonyl-Caliphatic, Caliphatic-amino, R-sulfonyl, Rsulfonyl-Caliphatic, R-aminosulfonyl, Raminosulfonyl-Caliphatic, R-sulfonylamino, R-sulfonylamino-Caliphatic, aminosulfonylamino, di-Caliphatic amino, di-Caliphatic aminocarbonyl, di-Caliphatic aminosulfonyl, di-Caliphatic amino, di-Caliphatic aminocarbonyl, di-Caliphatic aminosulfonyl-Caliphatic, (R)-Arylamino, (R)-Arylsulfonyl, (R)-Aryl-aminosulfonyl, (R)-Aryl-sulfonylamino, Het-amino, Het-sulfonyl, Het-aminosulfonyl, aminoiminoamino, or aminoiminoaminosulfonyl, Ris hydrogen; and further wherein Rand Rare optionally joined to form a fused ring, pharmaceutical formulations comprising them and their use in therapy, especially in the treatment of diseases mediated by CDK2 activity, such as alopecia induced by cancer chemotherapy or radiotherapy.